Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06269003
Other study ID # STUDY00001223
Secondary ID 1K99CA281094-01A
Status Completed
Phase N/A
First received
Last updated
Start date February 8, 2024
Est. completion date June 10, 2024

Study information

Verified date June 2024
Source University of Massachusetts, Worcester
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to use psychophysiological methods to test the effects of a message source (expert and peer) and message presentation types (one-sided and two-sided) to identify the optimal message type for young adults who vape and do not vape.


Recruitment information / eligibility

Status Completed
Enrollment 112
Est. completion date June 10, 2024
Est. primary completion date June 10, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 24 Years
Eligibility Inclusion Criteria: - Ages 18-24 - Fluent in English - Either vaping in the past 30 days or not having vaped in the past 30 days but susceptible to vaping - Self-reported abstinence of combusted tobacco or marijuana at time of visit Exclusion Criteria: - Ages below 18 or above 24 - Not fluent in English - Not confirmed self-reported abstinence of combusted tobacco or marijuana at time of visit

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Expert
Participants will view a brief description of an expert source.
Peer
Participants will view a brief description of a peer source.
1 Sided
Participants will view e-cigarette education messages in two-sided.
2 Sided
Participants will view e-cigarette education messages in two-sided.

Locations

Country Name City State
United States UMass Chan Medical School Shaw Building Worcester Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
University of Massachusetts, Worcester National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual attention Participants will view one of four text-based e-cigarette education messages that are manipulated on the source and message presentation type. Participants will be randomly assigned to one of the following message type: 1) expert one-sided, 2) expert two-sided, 3) peer one-sided, 4) peer two-sided. We selected messages that were previously tested for effective themes and contents with young adults and adapted the features to two source (expert and peer) and presentation (one-sided and two-sided) types. Higher scores indicate greater visual attention. 45 minutes
Primary Orienting response Orienting response, conceptualized as cognitive resources allocated to encode a message into working memory will be operationalized as heart rate using a Shimmer3 Unit with an electrode placed on the forefinger of the non-dominant hand. This is a well-established measure for cognitive resources devoted to stimuli processing. Lower scores indicate greater cognitive allocation of resources. 45 minutes
Primary Arousal Arousal, an indicator of physiological activation in the sympathetic nervous system, will be measured by sampling skin conductance using a 30 Hz Shimmer Galvonic Skin Response on finger sensors.Higher scores indicate greater arousal. 45 minutes
Secondary Attitudes Attitudes will be measured by seven-item vaping attitudes questionnaire, such as vaping is unenjoyable/enjoyable, unhealthy/healthy, dangerous/safe, boring/fun, stupid/smart, not cool/cool, and not attractive/attractive on a five-point bipolar scale. Higher scores indicate worse outcomes. 45 minutes
Secondary Behavioral intentions Behavioral intentions to vape will be measured by a three-item behavioral intentions questionnaire, such as intentions to vape (for vapers)/try vaping (for non-vapers) soon, anytime during the next year, would use offered by one of their best friends on a scale from 1 (Definitely not) to 5 (Definitely yes). Higher scores indicate worse outcome. 45 minutes
See also
  Status Clinical Trial Phase
Completed NCT05037656 - Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths N/A
Recruiting NCT05454267 - Early Detection of Vaping-related Vascular Diseases
Enrolling by invitation NCT04678245 - Network Intervention to Prevent Vaping N/A
Recruiting NCT06297005 - The Impact of E-cigarettes During Pregnancy on Childhood Health Outcomes Study
Not yet recruiting NCT05999383 - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration Phase 2
Completed NCT04522362 - Modeling Stress-precipitated Vaping Behavior N/A
Completed NCT04054765 - A Virtual Reality Videogame for E-cigarette Prevention in Teens N/A
Recruiting NCT06291597 - Vaping Adverse Lung and Heart Events Cohort
Active, not recruiting NCT04919590 - Text Message Quit Vaping Intervention for Adolescents N/A
Completed NCT04568395 - Acute Effects of TCIG vs ECIG in PLWH N/A
Completed NCT04707911 - Social Media Intervention to Stop Nicotine and Cannabis Vaping Among Adolescents N/A
Withdrawn NCT04340700 - Characterization of the Pharmacodynamic Response to Vaped THC Phase 3
Not yet recruiting NCT06335329 - Point-of-Care Ultrasound (POCUS) Findings and Impact on Vaping N/A
Completed NCT06433466 - Influencer Marketing: a Survey-based Experiment N/A
Active, not recruiting NCT05488743 - Smoking Prevention Program in Poland
Terminated NCT05240027 - To Vape or Not to Vape N/A
Recruiting NCT04661683 - Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol N/A
Completed NCT04450537 - PACE Vape Messaging Study N/A
Active, not recruiting NCT05367492 - Varenicline for Nicotine Vaping Cessation in Adolescents Phase 4
Completed NCT04879225 - Menthol and Mint Experimental Tobacco Marketplace (ETM) Study N/A